U.S. market Closed. Opens in 17 hours 18 minutes

ANEB | Anebulo Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-06-302022-06-302021-06-302020-06-30
RevenueN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/A
Operating Expenses11.78M6.83M3.61M173.35K
Selling, General & Admin6.18M3.87M1.34M23.35K
Research & Development5.60M2.96M2.27M150.00K
Other Operating Expenses-41.15K-1.78K-1.34KN/A
Operating Income-11.78M-6.83M-3.61M-173.35K
Other Expenses / Income-41.15K5.55K-26.64M-1.29K
Before Tax Income-11.73M-6.83M-30.25M-174.64K
Income Tax Expenses-104.19K-12.89K10.75K-1.04K
Net Income-11.73M-6.81M-30.26M-174.64K
Interest ExpensesN/A7.33K11.77K1.29K
Basic Shares Outstanding25.07M23.34M23.34M23.72M
Diluted Shares Outstanding25.07M23.34M23.34M23.72M
EBITDA-11.78M-6.83M-3.61M-173.35K
EBITDA Margin0.00%0.00%0.00%0.00%
EBIT-11.84M-6.82M-30.24M-174.39K
EBIT Margin0.00%0.00%0.00%0.00%
Financial Year End2023-06-302022-06-302021-06-302020-06-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙